September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
Pneumonic Plague's Killing Ability Hinges On Single Protein
January 25th 2007ST. LOUIS -- In a finding with potential antibioterror implications, a key protein's absence appears to slow the deadly attack of pneumonic plague, potentially making it susceptible to antibiotic treatment, according to researchers here.
Watchful Waiting for Ear Infection Safe for Language Acquisition
January 17th 2007PITTSBURGH -- Small children with persistent middle-ear effusion who did not get immediate insertion of tympanostomy tubes developed as well as peers given rapid treatment when they grew to ages nine to 11 years, investigators here reported.
Post-Peripartum Use of Viramune Safe After Six-Month Wait
January 11th 2007BOSTON -- For women in developing countries who are HIV-positive, a dose of Viramune (nevirapine) during labor to prevent mother-to-child viral transmission does not preclude the safe renewed use of Viramune-based antiretroviral therapy after a six-month delay.
Editorial Comment: Within Our Reach–The End of Perinatal HIV Transmission
January 1st 2007The elimination of perinatal HIV transmission in the United States is within reach. When antiretroviral therapy is effective in controlling maternal viremia during pregnancy, the risk of perinatal transmission is less than 1%.
Research Focus: Hepatitis C Update
January 1st 2007Liver disease, particularly hepatitis C, has emerged as a major cause of morbidity and mortality for people with HIV/AIDS in the era of potent antiretroviral therapy. Mortality is increased in patients with HIV–hepatitis C virus (HCV) coinfection compared with that in patients with HIV alone.1,2